Evidence map›Paper›PMID 18835926›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2009

In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.

Teruyo Nakatani, Bara Sarraj, Mutsuko Ohnishi, Michael J Densmore, Takashi Taguchi, Regina Goetz, Moosa Mohammadi, Beate Lanske, M Shawkat Razzaque

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 251 citations in OpenAlex.

  1. FGF23, Frailty, and Falls in SPRINT.Journal of the American Geriatrics Society · 2021
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  7. Preeclampsia as a Study Model for Aging: The Klotho Gene Paradigm.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Review
  10. Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.International journal of molecular sciences · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Teruyo NakataniDepartment of Developmental Biology, Harvard School of Dental Medicine, 188 Longwood Ave., Boston, MA 02115, USA.
Bara Sarraj
Mutsuko Ohnishi
Michael J Densmore
Takashi Taguchi
Regina Goetz
Moosa Mohammadi
Beate Lanske
M Shawkat Razzaque
Harvard University · USNew York University · USNagasaki University · JPUniversity of Nagasaki · JP

Funding

MECHANISMS OF FGF RECEPTOR REGULATION AND SIGNALINGR01DE013686 · NIDCR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOHAMMADI, MOOSA · 2000 to 2020
$12.3M
Pathophysiologic Regulation of Fgf-23 in Phosphate Homeostasis: Role of Vitamin DR01DK073944 · NIDDK · HARVARD MEDICAL SCHOOL · PI MANNSTADT, BEATE · 2007 to 2010
$1.7M
In vivo interactions of Fgf-23, klotho and vitamin DR01DK077276 · NIDDK · HARVARD MEDICAL SCHOOL · PI RAZZAQUE, MOHAMMED S · 2007 to 2011
$1.5M
NIDCR NIH HHS R01 DE013686NIDCR NIH HHS R01-DE13686NIDDK NIH HHS R01 DK073944NIDDK NIH HHS R01-DK073944NIDDK NIH HHS R01 DK077276NIDDK NIH HHS R01-DK077276
6 · The paper itself

Abstract

A major breakthrough in systemic phosphate homeostasis regulation was achieved by the demonstration of strikingly similar physical, morphological, and biochemical phenotypes of fibroblast growth factor 23 (Fgf23) and klotho ablated mice, which led to identification of klotho as an Fgf23 signaling cofactor. Here, we generated Fgf23 and klotho double-knockout (Fgf23(-/-)/klotho(-/-)) mice to test the hypothesis whether Fgf23 has a klotho-independent function. Fgf23(-/-)/klotho(-/-) mice are viable and have high serum phosphate levels, similar to Fgf23(-/-) and klotho(-/-) single-knockout mice. In addition, the Fgf23(-/-)/klotho(-/-) mice have increased renal expression of the sodium/phosphate cotransporter NaP(i)2a and of 1- alpha-hydroxylase concomitant with increased serum levels of 1,25-dihydroxyvitamin-D, as also observed in the Fgf23(-/-) and klotho(-/-) mice. Moreover, Fgf23(-/-)/klotho(-/-) mice show soft tissue and vascular calcification, severe muscle wasting, hypogonadism, pulmonary emphysema, distention of intestinal wall, and skin atrophy, all of which are also seen in Fgf23(-/-) and klotho(-/-) mice. Notably, injection of bioactive FGF23 protein into Fgf23(-/-)/klotho(-/-) and klotho(-/-) mice does not lower serum phosphate, whereas in wild-type and Fgf23(-/-) mice, it reduces serum phosphate. Together, these results provide compelling evidence that Fgf23 does not have a klotho-independent role in the regulation of systemic phosphate and vitamin D homeostasis.

Indexed as

HomeostasisAnimalsFibroblast Growth Factor-23Fibroblast Growth FactorsGlucuronidaseKidneyKlotho ProteinsMiceMice, KnockoutPhenotypePhosphatesSodium-Phosphate Cotransporter Proteins, Type IIaSurvival RateUrinalysisFgf23 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsGlucuronidaseKlotho ProteinsPhosphatesSodium-Phosphate Cotransporter Proteins, Type IIa

Identifiers

PMID18835926
PMCPMC2630784
OpenAlexW2004167485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.